Skip to main content
Online First
Original Research, Acute Lymphoblastic Leukemia, Anticoagulants, Thromboembolism
Evaluation of Clotting and Bleeding Risk Associated With the Use of Asparaginase Drugs in Patients With Acute Lymphoblastic Leukemia
Alyssa Cendagorta, PharmD, BCOP; Frank Lattuca, PharmD, BCOP; Jeremiah E. Moore, PharmD, BCOP; Kristen O’Dwyer, MD; Andrea Baran, MS; Nicole M. Acquisto, PharmD, FASHP, FCCM, FCCP, BCCCP; Carissa Treptow, PharmD, BCOP
Read More
A Dose Escalation Strategy for HR+/HER2− Early Breast Cancer: An Educational Video Series
Interview with the Innovators
Improving Abemaciclib Tolerability: Insights From the TRADE Dose-Escalation Study
Jamie Carroll, APRN, CNP, MSN
Read More
A Dose Escalation Strategy for HR+/HER2− Early Breast Cancer: An Educational Video Series
Interview with the Innovators
Managing Abemaciclib Side Effects: Practical Tips for Improving Patient Care
Jamie Carroll, APRN, CNP, MSN
Read More
A Dose Escalation Strategy for HR+/HER2− Early Breast Cancer: An Educational Video Series
Interview with the Innovators
Managing Abemaciclib Toxicity: Proactive Strategies for Improved Patient Outcomes
Heather Moore, PharmD, BCOP, CPP
Read More
A Dose Escalation Strategy for HR+/HER2− Early Breast Cancer: An Educational Video Series
Interview with the Innovators
Insights From the TRADE Study: Optimizing Abemaciclib Dose Escalation for Better Tolerability and Adherence
Heather Moore, PharmD, BCOP, CPP
Read More
A Dose Escalation Strategy for HR+/HER2− Early Breast Cancer: An Educational Video Series
Interview with the Innovators
TRADE Study Insights: A New Approach to Improve Abemaciclib Tolerability in Breast Cancer Care
Erica Mayer, MD, MPH
Read More
A Dose Escalation Strategy for HR+/HER2− Early Breast Cancer: An Educational Video Series
Interview with the Innovators
Optimizing Adjuvant Abemaciclib: Insights From the TRADE Study on Dose Escalation and Tolerability
Erica Mayer, MD, MPH
Read More
Original Research, Anticoagulants, Multiple Myeloma, Thromboembolism
Safety and Efficacy of Direct Oral Anticoagulants as Thromboprophylaxis in Patients With Multiple Myeloma Receiving a Lenalidomide-Based Induction Regimen
Christopher Wang, PharmD, BCOP; Chelsea Luo, PharmD, BCOP; Brian Primeaux, PharmD, BCOP
Read More
Original Research, Adverse Events, PARP Inhibitors
Prospective Pharmacist-Led Monitoring of Patients Initiating PARP Inhibitor Therapy in the United States
Brooke D. Looney, PharmD, CSP; Stephanie G. White, PharmD, CSP; Ryan Moore, MS; Autumn D. Zuckerman, PharmD, BCPS, CSP; Leena Choi, PhD, et al.
Read More
Early Breast Cancer
Case-Based Exchanges
Early Breast Cancer Part 3: Adverse Event Management - Patient Case #1
Joyce O’Shaughnessy, MD
Read More
Page 3 of 193
Results 21 - 30 of 1925